Circadiance has acquired the SmartMonitor and NeoPAP product lines from Philips, which includes the infant apnea monitoring technologies and infant positive airway pressure (PAP) technologies associated with these brands. The acquisition of these products and related intellectual property allow Circadiance to enter the global pediatric respiratory market.
David Groll, CEO of Circadiance, says in a release, “Home infant cardiorespiratory monitoring is an established market dominated by SmartMonitor’s proven technology, which offers at-risk infants a smooth transition from hospital to home. NeoPAP represents the future of respiratory care in neonatal patients with respiratory distress syndrome. It’s an exciting combination that we intend to leverage with future innovation.”
Circadiance develops, manufactures, and markets respiratory products for people with sleep-disordered breathing or who need non-invasive ventilation, including its SleepWeaver line of soft cloth CPAP masks. “This transaction between two established respiratory companies combines trusted product lines for home care providers,” says Groll. “As a company focused on respiratory care, Circadiance is well positioned to support the existing customers for these products and to expand distribution.”
The acquired products will be accretive to Circadiance, while complementing the company’s existing business. NeoPAP’s intuitive user interface, combined with SleepWeaver’s mask technology and the monitoring power of SmartMonitor, enable a unique continuum of care offering for pediatric patients, the company says. “With an expanded product portfolio, we enter the next phase of our company’s evolution, consistent with our mission to provide superior, cost effective outcomes to patients and their caregivers,” Groll says.
Both Circadiance and Philips are committed to a seamless transition of products, which is anticipated to be completed by the end of this week.
